TWO SIGMA INVESTMENTS, LP
Position in CATX — Perspective Therapeutics, Inc.
CIK 1179392
NEW YORK, NY
Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,184,486
+$888,215 QoQ
Shares Held
1,003,474
-16.3% QoQ
Ownership
0.880%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $2,221,263,395 across 63 Medical Devices names. CATX ranks #29 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
6,388,828 | $655,940,970 | |
| 2 | BSX |
Boston Scientific Corp
|
9,411,231 | $590,554,745 | |
| 3 | PODD |
Insulet Corp
|
762,349 | $159,971,314 | |
| 4 | SYK |
Stryker Corp
|
469,215 | $154,179,356 | |
| 5 | STE |
STERIS plc
|
479,146 | $105,953,554 | |
| 6 | EW |
Edwards Lifesciences Corp
|
1,051,535 | $84,206,922 | |
| 7 | DXCM |
Dexcom Inc
|
1,114,948 | $70,018,734 | |
| 8 | MDT |
Medtronic plc
|
605,568 | $52,472,467 |
All Filings in CATX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,184,486 | 1,003,474 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,296,271 | 1,198,644 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,782,461 | 519,668 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,070,209 | 601,805 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,309,515 | 614,796 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,074,619 | 650,351 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||